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Abstract 
To study the associations of polymorphisms of the NDRG1 gene, which is differentially expressed in 
the placenta, with the risk of preeclampsia (PE) development. The study group included 997 women: 
366 pregnant women with preeclampsia and 631 women with physiological pregnancy. Clinical and 
laboratory examination of pregnant women was carried out in the Perinatal Center of the Belgorod 
Regional Clinical Hospital of St. Joasaph. DNA was isolated from peripheral venous blood 
lymphocytes by phenol-chloroform extraction. All women underwent typing of four single nucleotide 
polymorphisms of the N-myc downstream regulated gene 1 (NDRG1). The analysis of SNPs 
associations with the development of preeclampsia was performed using logistic regression analysis 
within the framework of additive, dominant and recessive genetic models. The average age in the 
group with preeclampsia was 0.75 years higher compared to the control group (p = 0.01). Among 
pregnant women with PE, body weight and body mass index exceeded those of the control group (p 
= 0.0001). Also, in this group, the percentage of women with obesity is 2.26 times higher (p = 0.001). 
The analysis of risk factors for PE revealed a higher incidence of arterial hypertension before 
pregnancy and a history of preeclampsia in the patient group as compared with the control (p = 
0.0001). Compared with the control group, women with PE have a greater number of pregnancies 
(1.32 times, p = 0.03) due to a greater number of stillbirths (p = 0.02), miscarriages (0.01), and 
artifactual abortions (p = 0.0005). The rs12678229 NDRG1 allele A was found to be associated with 
the development of preeclampsia in the framework of the recessive model (OR = 1.46, 95% Cl 1.01-
2.12, p = 0.046). The associations of other studied polymorphic markers with the development of 
preeclampsia were statistically insignificant. Thus, the rs12678229 NDRG1 allele is a risk factor for 
the development of preeclampsia among the women of the Central Black Earth Region of Russia. 
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INTRODUCTION 
Preeclampsia (PE) is a multisystem pathological 
condition that occurs in the second half of pregnancy 
(after the 20th week), characterized by arterial 
hypertension in combination with proteinuria (≥3 g/l in 
daily urine), often with edema and manifestations of 
multiple organ / multisystem dysfunction / failure (Abalos 
et al. 2014; Suparman et al., 2018). 
According to world literature and WHO, the incidence 
of preeclampsia is 2-8% (Duley, 2009; Abalos et al., 
2014). PE remains an important cause of maternal, 
perinatal, and neonatal morbidity and mortality (Abalos 
et al., 2014; Voge et al., 2014). 
With the development of severe preeclampsia and 
eclampsia, the risk of such complications as 
hemorrhage and cerebral edema, placental abruption, 
Disseminated Intravascular Coagulation (DIC), massive 
obstetric hemorrhage, HELLP syndrome, hemorrhage 
and rupture of the liver capsule, pulmonary edema, 
respiratory distress syndrome among adults, acute renal 
and hepatic insufficiency increases significantly (Abalos 
et al., 2014). 
Children born after preeclampsia have a low weight 
and an increased risk of stroke, coronary heart disease, 
and metabolic syndrome in adulthood (Abalos et al., 
2014; Bilano et al., 2014). 
Numerous studies indicate the multifactorial nature 
of preeclampsia, which suggests an assessment of the 
genetic component in the development of this pregnancy 
complication. Currently, research on the molecular 
genetic study of preeclampsia is being actively 
conducted around the world. 
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One of these types of studies is genome-wide 
association studies (GWAS) of single nucleotide 
polymorphisms with the development of preeclampsia 
(Johnson et al., 2012; Zhao et al., 2013). Another field 
of the molecular genetic study of PE is the study of 
candidate genes differentially expressed in the placenta 
(Loset et al., 2011; Louwen et al., 2013; Trifonova et al., 
2014; Serebrova et al., 2016). A more common 
approach in the molecular genetic study of preeclampsia 
and its clinical manifestations (arterial hypertension, 
proteinuria, etc.) is related with associative studies 
(Williams et al., 2011; Williams, Morgan, 2012; 
Polonikov et al., 2015; Yarosh et al., 2015; Reshetnikov 
et al., 2015; Polonikov et al., 2017a; Polonikov et al., 
2017 b; Reshetnikov et al., 2017; Sirotina et al., 2018; 
Golovchenko, 2019; Reshetnikov et al., 2019; Sami, et 
al, 2018). Dynamic Simulation and Modeling of a Novel 
Combined Hybrid Photovoltaic-Thermal Panel Hybrid 
System. International Journal of Sustainable Energy and 
Environmental Research, 7(1), 1-23).  
It should be noted that the results of the studies on 
the search for candidate gene associations with the risk 
of PE development are contradictory, which is 
associated with the genetic heterogeneity of different 
populations. 
MATERIALS AND METHODS 
The study group included 997 women: 366 pregnant 
women with preeclampsia and 631 women with normal 
pregnancy (control group). 
The studied samples included the women of Russian 
nationality who were born in the Central Black Earth 
Region of Russia, who had no kinship among 
themselves, who lived in the Belgorod Region and 
voluntarily agreed to conduct the study. Clinical and 
laboratory examination of pregnant women was carried 
out on the basis of the Perinatal Center of the Belgorod 
Regional Clinical Hospital of St. Joasaph. 
The study was approved by the ethics committee of 
the Belgorod National Research University. All 
participants signed informed consent to participate in 
this study. 
The diagnosis of preeclampsia was made on the 
basis of generalized edema, arterial hypertension and 
proteinuria. DNA was isolated from peripheral venous 
blood lymphocytes by phenol-chloroform extraction. 
Genotyping of DNA samples was performed by the 
method of matrix-activated laser desorption/ionization 
(MALDI) on the iPLEX platform of the MassARRAY 
Analyzer 4 mass spectrometer (“Seqeunom”) at the 
Scientific Research Institute of Medical Genetics of the 
Tomsk National Research Medical Center of the 
Russian Academy of Sciences. All women underwent 
typing of four single nucleotide polymorphisms of N-myc 
downstream regulated 1 gene (NDRG1): A / G NDRG1 
(rs2977559), T / C NDRG1 (rs2227262), A / G NDRG1 
(rs12678229), T / C NDRG1 (rs3802252). Differences in 
the studied traits between the compared groups were 
evaluated using the Kruskal – Wallis method. The 
analysis of SNP associations with the development of 
preeclampsia was performed using logistic regression 
analysis in the framework of additive, dominant and 
recessive genetic models (Ponomarenko et al., 2019). 
The study was carried out taking into account correction 
for covariates: age, body mass index, the history of 
artifactual abortions, the history of stillbirths, the 
presence of hypertension before pregnancy, and the 
history of preeclampsia. The odds ratio (OR) indicators 
and their 95% confidence interval (95% CI) were 
calculated. 
They estimated the observed distribution of 
genotypes by 4 SNPs included in the analysis, and its 
correspondence to the expected distribution, according 
to Hardy – Weinberg equilibrium, the observed (Ho) and 
expected (He) heterozygosity were calculated. 
RESULTS 
The main biomedical and clinical-anamnestic 
characteristics of the studied groups of pregnant women 
are presented in Table 1. 
The average age in the group with preeclampsia was 
0.75 years higher as compared with the control group (p 
= 0.01). Among the pregnant women with PE, body 
weight and body mass index exceeded those of the 
control group (p = 0.0001). Also, the percentage of 
women with obesity in this group is 2.26 times higher (p 
= 0.001). 
During the analysis of PE risk factors, they revealed 
a higher incidence of arterial hypertension before 
Table 1. Biomedical characteristics of the studied groups of pregnant women 
Indicators 
Pregnant women with preeclampsia 
(n =366) 
Х̅ ± SD/%(n) 
Control 
(n =631) 
Х̅ ± SD/%(n) 
P 
Age, years (min - max) 27.32±5.17 26.57±4.94 0.01 
Height, m 1.65±0.05 1.65±0.06 0.52 
Weight, kg 69.46±15.76 63.50±11.22 0.0001 
BMI, kg/m2 25.65±5.71 23.40±3.47 0.0001 
The distribution of individuals by BMI, % (n): 
lack of weight (<18.50) 












Note: BMI – body mass index; Р – the significance level of differences between the compared groups according to the Kruskal-Wallis test 
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pregnancy and a history of preeclampsia in the patient 
group as compared with the control (p = 0.0001). 
As compared with the control group, the women with 
PE differ by a large number of pregnancies (1.32 times, 
p = 0.03) due to a greater number of stillbirths (p = 0.02), 
miscarriages (0.01), and artifactual abortions (p = 
0.0005). 
They studied the distribution of 4 polymorphic loci 
among the studied groups of pregnant women. For all 
SNPs studied, both in the group of pregnant women with 
PE and in the control group, the frequencies of minor 
alleles (MAF) were 5% higher. The analysis of the 
observed distribution of genotypes did not reveal 
deviations from the expected distribution in accordance 
with Hardy-Weinberg equilibrium (HWE) (p > 0.05). 
At the next stage, using the logistic regression 
analysis in the framework of additive, dominant and 
recessive genetic models, they performed the analysis 
of NDRG1 gene polymorphism associations with a risk 
of preeclampsia. At the same time, biomedical and 
clinical-anamnestic indicators, according to which 
significant differences were found between the studied 
groups of pregnant women, were used as covariates. 
The results are presented in Table 2. 
The rs12678229 NDRG1 allele A was found to be 
associated with the development of preeclampsia in the 
framework of the recessive model (OR = 1.46, 95% Cl 
1.01-2.12, p = 0.046). 
The associations of other polymorphic markers 
studied with the development of preeclampsia were 
statistically insignificant. 
DISCUSSION 
The results of this study indicate a connection 
between rs12678229 NDRG1 polymorphism and the 
risk of preeclampsia development among pregnant 
women of the Central Black Earth Region of Russia. 
Other studies have also examined the role of the 
NDRG1 gene in the formation of preeclampsia. Thus, in 
the study on the Siberian population, including 
Russians, Yakuts and Buryats, they determined the 
associations of polymorphisms rs12678229, rs2227262 
and rs2227262 and rs2227262 NDRG1 with an 
increased risk of preeclampsia (Serebrova et al., 2016). 
A number of other studies have evaluated the effect 
of NDRG1 expression in the placenta on preeclampsia 
development (Choi et al., 2007; Fu et al., 2017). So, Choi 
et al. (2007) revealed an increased level of NDRG1 
expression in placentas of women with PE. In the work 
by Fu et al. (2017) an increased expression of NDRG1 
was also established, and in placentas with early PE, the 
expression level was higher as compared to the 
placentas with late PE. 
According to published data, the isoform of the 
NDRG1 protein, which is a member of the NDRG family, 
is most actively expressed in the placenta during the 
second and the third trimester of pregnancy, mainly in 
syncytiotrophoblast. Activation of NDRG1 gene 
expression in trophoblast cells is carried out under 
conditions of hypoxia (Chen et al., 2006; Choi et al., 
2007). 
Violation of cytotrophoblast invasion under hypoxia 
leads to placental hypoperfusion, the development of 
oxidative stress and inflammation, and the appearance 
of systemic endothelial dysfunction, which is responsible 
for the characteristic clinical manifestations of 
preeclampsia (Hansson S.R. et al., 2014). 
Thus, the results of the study indicate that the 
rs12678229 NDRG1 allele is a risk factor for the 
development of preeclampsia among the women of the 
Central Black Earth region of Russia. The data obtained 
expand the existing understanding of genetic factor role 
in the development of preeclampsia and allow the future 
use of these data to predict or detect this pregnancy 
complication. 
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